Clinuvel Pharmaceuticals Limited CLVLY
6.74 USD 0.00 (+0.00%)
Aug 10, 2026, 9:30 AM EDT
6.74 Day range 6.74
5.98 52-week range 9.00
- YTD
- -20.52%
- 1 year
- -3.44%
- Market cap
- 339.88M
- EPS (ttm)
- 0.465
- P/E ratio
- 14.49
- YTD return
- -20.52%
- 1-year return
- -3.44%
- Volume
- 152
- Avg volume
- 3.00K
- Open
- 6.74
- Previous close
- 6.74
- Day's range
- 6.74 – 6.74
- 52-week range
- 5.98 – 9.00
2Y -1.63 (-18.15%)
News
A decade of profitability provides foundation for CLINUVEL's U.S. expansion 
CLINUVEL implements strategic reorganisation to refocus on U.S. markets 
CLINUVEL's ADS to commence trading on Nasdaq 
SCENESSE® approved for EPP in Canada 
CLINUVEL receives final EMA scientific advice for pivotal Phase III vitiligo study 
CLINUVEL: advancing peptides for photomedicine and vitiligo care at AAD 2026 
Clinuvel Pharmaceuticals Limited (CLVLY) Q2 2026 Earnings Call Transcript 
Clinuvel Pharmaceuticals Limited (CLVLY) Shareholder/Analyst Call Transcript 
CLINUVEL to advance novel pharmaceutical formulations in preclinical program 
Clinuvel Pharmaceuticals Limited (CLVLY) Q4 2025 Earnings Call Transcript
Your note
Sign in to keep a note on CLVLY — it syncs with the Stock Master app.